Navigation Links
Bioniche Reports Fiscal 2008 Second Quarter
Date:2/8/2008

ompany's education and awareness program focused on the dangers of E. coli O157:H7 and the importance of food and environmental safety.

Gross research and development expenses were $7.2 million for the six-month period ending December 31, 2007. This is unchanged from the same period in Fiscal 2007. The majority of these costs can be attributed to the ongoing Phase III clinical program with Urocidin(TM) in bladder cancer.

The basic net loss per share for the six-month period ending December 31, 2007 was ($0.13), compared to a net loss per share of ($0.14) recorded in the same period last year.

The balance sheet at December 31, 2007 shows:

- Total assets of $36.8 million, as compared to $41.5 million at

June 30, 2007.

- Working capital of $7.1 million, as compared to $14.4 million at

June 30, 2007.

- Shareholders' equity of $21.7 million, as compared to $29.1 million

at June 30, 2007.

- Cash and cash equivalents of $6.6 million, as compared to cash, cash

equivalents and short-term investments of $11.0 million at June 30,

2007.

- Unused revolving credit facilities of $1.6 million, as compared to

$1.8 million at the end of June 30, 2007.

"It is important to note that despite some going concern with our cash position, our commercial operations continue to perform nicely," said Patrick Montpetit, Chief Financial Officer of Bioniche Life Sciences Inc. "We are well positioned and committed to execute a strategic partnership transaction related to the financing of our bladder cancer therapy, Urocidin(TM), at the earliest opportunity."

The Company will discuss its second quarter results and other recent news during a:

Conference Call & Audio Web Cast

Tuesday, February 12, 2008

9:00 a.m. (Eastern)

To participate in the teleconference, call 4
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Bioniche Reports Fiscal 2008 First Quarter
8. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
9. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
10. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
11. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Allegheny Health Network ... partnership designed to advance sports nutrition education, concussion ... athletes, scholastic athletes and their families across western ... Mind Initiative will offer a comprehensive and multi-disciplined ... mental dynamics involved in pursuing athletic excellence,” said ...
(Date:8/28/2014)... Vernon, Ind. (PRWEB) August 28, 2014 ... of Valero Energy Corporation (NYSE: VLO), and the Ports ... state and local officials today at a Port Appreciation ... purchased Mount Vernon ethanol plant. , “The opening of ... Vernon is another economic development win for the ...
(Date:8/28/2014)... Gurnick Academy of Medical Arts is proud ... for the 5 years of the accreditation cycle by ... , “We are very proud to have earned the ... make sure we provide the best experience to our ... field nowadays and I look forward to see more ...
(Date:8/28/2014)... HealthDay Reporter THURSDAY, Aug. 28, ... currents through the scalp to a specific network of brain ... In a small study of healthy young adults, researchers ... involved in memory. That, in turn, boosted participants, performance on ... brain stimulation. During TMS, an electromagnetic coil is placed ...
(Date:8/28/2014)... A chronic problem in winemaking is "stuck fermentation," when ... alcohol and carbon dioxide prematurely shuts down, leaving the ... can spoil the wine. , A team of researchers ... a biochemical communication system behind this problem. Working ... can reproduce itself -- the system enables bacteria in ...
Breaking Medicine News(10 mins):Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 2Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 3Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 4Health News:Valero, Ports of Indiana Celebrate Restart of Ethanol Plant 2Health News:Valero, Ports of Indiana Celebrate Restart of Ethanol Plant 3Health News:Gurnick Academy’s MRI Program Is Re-Accredited by ARMRIT for the 5 Years 2Health News:Electrical Pulses to Scalp May Boost Memory: Study 2Health News:Electrical Pulses to Scalp May Boost Memory: Study 3Health News:Prions can trigger 'stuck' wine fermentations, researchers find 2
... Dengue fever has infected almost 20,000 people in Vietnam in ... seven more than in the same period last year, the ... have been blamed for the nearly 15 percent rise to ... concentrated in the poverty-stricken southern Mekong delta. ,Malaysia ...
... figure of those wounded in the killing fields of Iraq or ... keep track of 3,500 in Iraq for instance. But in ... ,But more important the precise numbers it is the ... has caused concerns all round. ,More than 800 of ...
... crusade for the rights of mentally ill and disabled children ... motion last year. ,Rowling is carrying on ... children kept in cages in institutions in East Europe. ... Level Group, which fights for better rights for children in ...
... summer vibrates with expressions of insect love and desire. The ... how an emitting sex attracts conspecific members of the ... humans, are also signals by which females guide males towards ... tend to be very specific, hence they are thought to ...
... funny man Jim Carreys lady love Jenny McCarthy has revealed her ... actress insisted that the couple will be spending as much time ... beach. We like to sit and do nothing. Stare at the ... ,The 34-year-old will be spending a lot of time with her ...
... California, San Diego (UCSD) Skaggs School of Pharmacy and ... human vaccine to prevent against Human Cytomegalovirus (hCMV) ... herpes virus, is the leading viral cause of birth ... immune systems. The bodys natural immunity doesnt protect against ...
Cached Medicine News:Health News:US Trying Hard to Provide Proper Treatment for Wounded Soldiers 2Health News:US Trying Hard to Provide Proper Treatment for Wounded Soldiers 3Health News:US Trying Hard to Provide Proper Treatment for Wounded Soldiers 4Health News:JK Rowling Intensifies Her Disabled Children's Rights Crusade 2Health News:Another Sexual Attraction is Possible ... 2Health News:Human Vaccine for Herpes Virus on the Anvil 2Health News:Human Vaccine for Herpes Virus on the Anvil 3
(Date:8/28/2014)... 28, 2014 Tianyin Pharmaceutical Co., Inc. ... company that specializes in patented biopharmaceutical, modernized traditional ... ingredients (API) today updates the timeline for the ... The Company is scheduled to ... China Food & Drug Administration,s (CFDA) review in ...
(Date:8/28/2014)... 28, 2014  Decision Resources Group finds that the market ... $7.7 billion by 2023 in the United States ... , Italy , Spain ... Japan . The biosimilar erosion of Roche/Genentech/Chugai,s ... out by the launch of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s ...
(Date:8/28/2014)... , Aug. 28, 2014 Levi & ... commenced in the United States District Court for the ... of investors who purchased Galectin Therapeutics Inc. ("Galectin" or ... and July 28, 2014. For more information, ... alleges that during the Class Period the Company violated ...
Breaking Medicine Technology:TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2
... BEIJING, March 1, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical ... or the "Company"), an emerging leader in the ... and homecare medical products in China, today announced ... community conferences in March: (Logo: ...
... Diagnostics, Inc. announced today that the WARFARIN Study ( W ... or A dults R eceiving Genetic Testing at ... nationwide to assess the utility of genetic testing to determine ... risk of serious bleeding or clotting events. Warfarin, the most ...
Cached Medicine Technology:Dehaier Medical Announces March Investor Presentations 2WARFARIN Study Launched to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 2WARFARIN Study Launched to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 3
...
...
...
... Platform for Pure Harmonic Detection , ... in our ProSound line of superior ... technology provides distortion-free fundamental frequency transmission, ... This technology is especially effective for ...
Medicine Products: